Several studies have reported that activation of the β 2 AR can also stimulate the release of extracellular mediators as part of its signalling repertoire. Activation of the β 2 AR in mouse skeletal muscle, vascular smooth muscle cells or cardiac fibroblasts promotes the extracellular release of cAMP, which is converted to AMP by ecto-phosphodiesterases and then to adenosine by ecto-5'-nucleotidase on the extracellular surface of the cells (Dubey et al., 1996; 2001; Duarte et al., 2012) . In addition, extracellular adenosine can be produced by the release of intracellular adenine nucleotides to the extracellular space, which are converted to adenosine by ecto-ATPase, ecto-ADPase and ecto-5'-nuclotidase (Jackson et al., 1996) . Stimulation of human erythrocytes with isoproterenol (ISO) increases extracellular ATP levels (Montalbetti et al., 2011) , suggesting that βARs can also be coupled to ATP release. In some cases, this release of mediators into the extracellular milieu can lead to the subsequent transactivation of other GPCRs or receptor tyrosine kinases. Previously, an "inside-out" signalling mechanism was demonstrated for the β 2 AR, leading to the transactivation of adenosine receptors through the production of extracellular adenosine as described above (Sumi et al., 2010) , as well as the epithelial growth receptor (EGFR) through the membrane shedding of heparin-binding epithelial growth factor (HB-EGF) (Kim et al., 2002) .
In this study, we describe a new "inside-out" pathway activated by the β 2 AR in non-excitable cells, involving the Gs-dependent, but cAMP-independent increase in intracellular Ca 2+ through the release of extracellular ATP and the subsequent transactivation of Gq-coupled P2Y purinergic receptors, providing a previously unrecognised link between adrenergic and purinergic receptors. This study also provides the first description and use of CRISPR/Cas9 genomic editing to knockout Gs in human cells, providing a powerful new tool to explore the signalling events downstream of this G subunit. This article has not been copyedited and formatted. The final version may differ from this version.
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Materials and Methods:
Reagents: (-)-isoproterenol hydrochloride (ISO), carbamoylcholine chloride (Cch), thapsigargin (TG), 8-bromo-cAMP (8-br-cAMP), forskolin, cholera toxin (CTX), , suramin and apyrase were purchased from Sigma Aldrich (St. Louis, MO, USA). ICI118,551, 1,2-Bis(2aminophenoxy)ethane-N,N,N',N'-tetraacetic acid tetrakis(acetoxymethyl ester) (BAPTA-AM), 2-aminoethoxydiphenyl borate (2-APB), 9-(Tetrahydro-2-furanyl)-9H-purin-6-amine (SQ22536), , 8,8'-[Carbonylbis[imino-3,1-phenylenecarbonylimino(4-fluoro-3,1phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid hexasodium salt (NF157), 4,4'-(Carbonylbis(imino-3,1-(4-methyl-phenylene)carbonylimino))bis(naphthalene-2,6-disulfonic acid) tetrasodium salt (NF340), 8, phenylenecarbonylimino)]bis-1,3,5-naphthalenetrisulfonic acid hexasodium salt (NF279), N-Cyano-N"-[(1S)-1-phenylethyl]-N'-5-quinolinyl-guanidine (A-804598), 5-(3-Bromophenyl)-1,3dihydro-2H-benzofuro[3,2-e]-1,4-diazepin-2-one (5-BDBD), 9-Chloro-2-(2-furanyl)- [1, 2, 4] triazolo [1,5-c] quinazolin-5-amine (CGS 15943) and 4,4',4'',4'''-[Carbonylbis(imino-5,1,3- benzenetriyl-bis(carbonylimino))]tetrakis-1,3-benzenedisulfonic acid octasodium salt (NF449) were obtained from R&D Systems (Minneapolis, MN, USA). Coelenterazine 400a and coelenterazine h were purchased from Nanolight technologies (Pinetop, AZ, USA) and coelenterazine cp was purchased from Biotium (Hayward, CA, USA). Arginine-vasopressine (AVP) and 5-(Methylamino)-2-[[2R,3R,6S,8S,9R,11R) -3,9,11-trimethyl-8-[(1S)-1-methyl-2oxo-2-(1H-pyrrol-2-yl)-ethyl]-1,7-dioxaspiro[5.5]undec-2-yl]methyl]-4-benzoxazolecarboxylic acid (A23187) were from Tocris (Bio-Techne, Minneapolis, MN, USA). Cell culture reagents were from Wisent Incorporated (Montreal, QC, Canada). The Gq selective inhibitor, FR900359 (Schrage et al., 2015) was obtained from Dr. Eve Kostenis and Dr. Stefan Kehraus from the This article has not been copyedited and formatted. The final version may differ from this version.
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University of Bonn. The Gq and Gq(Q209L/D277N) constructs were purchased from Missouri S&T cDNA Resource Center (Rolla, MO, USA). Hap II, Pvu II and Hae II restriction enzymes were from Takara Bio (Japan). All other reagents were obtained from Sigma-Aldrich unless otherwise stated.
Cell culture and transfections: Parental HEK293S cells or HEK293S cells stably expressing an amino-terminal tagged human  2 AR (3.17 ± 0.32 pmol/mg protein; HA- 2 AR-HEK293S cells; Galandrin et al. 2006) were grown at 37°C with 5% CO 2 in Dulbecco's modified Eagle's medium (DMEM) supplemented with 5% fetal bovine serum. HEK293S and HA- 2 AR-HEK293S cells were transiently transfected (600 000 cells/well) in 6 well plates with biosensors (950 ng/110 6 cells) for Ca 2+ measurements (Obelin luminescence), bioluminescence resonance energy transfer (BRET) and fluorescence resonance energy transfer (FRET) assays using linear polyethylenimine (PEI; 1 mg/ml; Polysciences Inc., Warrington, PA) diluted in NaCl (150 mM, pH 7.0) (PEI:DNA ratio 3:1) as previously described (Reed et al., 2006) . Twenty four hours post-transfection, cells were re-plated (50,000 cells/well) onto white 96-well CulturePlates (Perkin-Elmer, Woodbridge, ON, Canada). Six hours after re-plating, growth medium was replaced with fresh starvation media consisting of DMEM supplemented with 0.5% FBS for the next 18 h.
Parental HEK293 and ∆Gs-HEK293 cells were cultured and transfected as described for the HEK293S cells, with the following modification: medium was supplemented with 10% FBS, PEI was diluted in Dulbecco's Phosphate-Buffered Saline (DPBS) and added to cells in suspension (300,000-350,000 cells/ml). Cells were then transferred into white 96-well CulturePlates (30,000-35,000 cells/well). Cells were cultured with 10% FBS for the following 48 hrs prior to experimentation. This article has not been copyedited and formatted. The final version may differ from this version. restriction enzyme digestion, using the primer and restriction enzyme combinations shown in Supplemental Table 1 . PCR was performed with an initial denaturation cycle of 95ºC for 2 min, followed by 35 cycles of 95ºC for 15 sec, 64ºC for 30 sec and 72ºC for 30 sec. The resulting PCR product was digested with the corresponding restriction enzyme and analyzed by agarose gel electrophoresis. Candidate positive clones were further analyzed by genomic DNA sequencing using a TA cloning method. The lack of functional Gs was also confirmed by assessing GPCR-stimulated cAMP production as described below. For the TA cloning, PCRamplified genomic DNA fragments using an ExTaq polymerase (Takara Bio, Japan) were gelpurified (Promega, WI, USA) and cloned into a pMD20 T-vector (Takara Bio, Japan). Ligated products were introduced into SCS1 competent cells (Stratagene, CA, USA) and transformed cells were selected on an ampicillin-containing LB plate. At least twelve colonies were picked and inserted fragments were PCR-amplified using the ExTaq polymerase and primers (5'-CAGGAAACAGCTATGAC-3' (M13 Primer RV) and 5'-GTTTTCCCAGTCACGAC-3' (M13 Primer M4)) designed to anneal the pME20 T-vectors. PCR products of the transformed pMD20 T-vector were sequenced using the Sanger method (FASMAC, Japan) and the M13 Primer RV.
Whole transcriptome expression profiling was performed using the Clariom S assay (human, analysis using the Transcriptome Analysis Console from Affymetrix) to assess differences in gene expression between the parental HEK293 and ∆Gs-HEK293 cell lines (Supplemental The gene expression microarray data was analyzed and normalized by the bioinformatics platform at the Institute for Research in Immunology and Cancer (IRIC) at the University of Montreal. The raw fluorescent values were then normalized using a quantile normalization method (Bolstad et al., 2003; Lemieux, 2006) , which re-ranks the sampled based on the raw fluorescent values obtained for each probe. Using this method of normalization, the distribution of the samples becomes the reference point, therefore, no internal control is required. For the microarray dataset analyzed, the distribution of the data is defined by the median value 7.162; the minimum value 5.851 and the maximum value 15.760, the first quartile of 6.578 and the third quartile of 9.215. The normalized values were plotted alongside known housekeeping genes, βactin and α-tubulin, which were used for comparison purposes to represent genes that are highly expressed in the cells. The inhibitory G protein, Gαo, was also plotted because it is not expressed in HEK293 cells (Law et al., 1993) and therefore represents an appropriate baseline background value.
Western blot analysis:
The parental HEK293 cells and the ∆Gs-HEK293 cells were harvested and approximately 1 x 10 6 cells were lysed in 500 µL of SDS-PAGE sample buffer (62.5 mM Tris-HCl (pH 6.8), 50 mM dithiothreitol, 2% SDS, 10% Glycerol and 4 M urea) containing 1 mM EDTA and 1 mM phenylmethylsulfonyl fluoride. Cell lysates were homogenized with a handy ultrasonic homogenizer (Microtech) and boiled at 95ºC for 5 min. Western blots were performed according to standard procedures using an anti-Gαs/olf mouse monoclonal antibody cat. no. sc55546, Santa Cruz Biotechnology) buffered saline, 5% skim milk, 0.05% Tween 20). Chemiluminescence signals were detected using a LAS-4000 (FujiFilm) and visualized with Multi Gauge ver. 3.0 (FujiFilm). Ca 2+ measurements: Ca 2+ measurements were carried out as described previously (van der Westhuizen et al., 2014) . Briefly, HEK293S, HA- 2 AR-HEK293S or ∆Gs-HEK293 cells were transiently transfected with the mCherry-obelin or GFP2-obelin-based Ca 2+ -sensitive biosensors.
The day of experimentation, cells were washed twice and pre-incubated in stimulation buffer (Modified Hank's Balances Salt Solution (HBSS): 137 mM NaCl, 5.4 mM KCl, 0.25 mM Na 2 HPO 4 , 0.44 mM KH 2 PO 4 , 1.8 mM CaCl 2 , 0.8 mM MgSO 4 , 4.2 mM NaHCO 3 , 0.2% (w/v) Dglucose, pH 7.4) containing the obelin substrate, coelenterazine cp (1 M), at 25°C for 2 h in the dark. Compounds diluted in stimulation buffer were injected into the wells and luminescence readings were taken every 0.3 seconds using the SpectraMax L (Molecular Devices, Sunnyvale, CA). Luminescence was monitored for a total of 60 seconds post-stimulation and expressed as relative luminescence units (RLU). The area under the resulting curves (AUC) and the peak response to stimulation were calculated. Where indicated, the AUC was transformed as % peak ISO or A23187 response. cAMP production: cAMP production measurements were carried out as described previously (van der Westhuizen et al., 2014) . Briefly, cells were transfected as indicated with either the FRET-based GFP10-EPAC1-vYFP or the BRET-based GFP 10 -EPAC1-RlucII cAMP-sensitive biosensors in which binding of cAMP induces a conformational change that leads to a decrease in FRET or BRET. Compounds were diluted in stimulation buffer and added to cells at 37°C for (Berthold Technologies, Bad Wildbad, Germany) using 410±70 nm (RlucII) and 515±20 nm (GFP 10 ) emission filters or the SynergyNeo microplate reader from BioTek using 41080 nm and 51530 nm emission filters. FRET or BRET ratios were calculated (acceptor/donor) and
∆FRET and ∆BRET were determined by subtracting the FRET or BRET signal generated in vehicle treatment control conditions. Measurements of cAMP for Figure 4A were performed using the HTRF-cAMP dynamic kit (Cisbio) as described previously (Stallaert et al., 2012) .
Gs activation assay:
HA- 2 AR-HEK293S cells were co-transfected with a three-component G protein activation biosensor composed of Gs-67-RlucII (50 ng/well), G1 (100 ng/well) and GFP 10 -G1 (100 ng/well) in which Gs activation results in the separation between the G and G subunits, thus leading to a decrease in BRET (Gales et al., 2005) . The day of the experiment, cells were washed twice with stimulation buffer and pre-treated with various inhibitors diluted in stimulation buffer for the indicated times at 37°C. Coelenterazine 400a, diluted in stimulation buffer (5 µM) was added to the wells for 5 min, then increasing concentrations of ISO were added for 2 min. Plates were read on the Mithras LB 940 with 410±70 nm (RlucII) and 515±20 nm (GFP 10 ) emission filters and BRET ratios calculated as above.
Quantification of extracellular ATP: Extracellular ATP was measured using the luciferinluciferase-based ENLITEN ® ATP Assay System (Promega, Madison, WI, USA) according to the manufacturer's instructions. Briefly, cells were grown to 90-100% confluence in a 96-well plate.
Cells were washed with stimulation buffer, then pre-treated with 10 µM ICI 118,551 or 
Results:  2 AR activation leads to an increase in intracellular Ca 2+ in HEK293S cells: Isoproterenol
(ISO) stimulation of the endogenously expressed β 2 ARs in HEK293S cells induces a rapid and transient increase in intracellular Ca 2+ ( Figure 1A ). The increase in intracellular Ca 2+ was detected as early as 5 seconds following the addition of ISO, reaching a maximum at approximately 12 seconds followed by a slow decrease thereafter and returning to basal levels 60 seconds post-stimulation, demonstrating a functional Ca 2+ response in non-excitable cells that endogenously express the receptor. Stable overexpression of the β 2 AR in HEK293S cells (HA- 2 AR-HEK293S cells) led to acceleration in the onset (≈ 2 sec) and increased magnitude of the response ( Figure 1B ). This increase in intracellular Ca 2+ was inhibited in both cell lines following pre-treatment with the  2 AR-selective antagonist, ICI 118,551, confirming the  2 ARspecificity of the response ( Figure 1C ). The response was concentration-dependent, yielding similar pEC 50 values for ISO in both cell lines (7.32±0.10 and 7.05±0.16 in HEK293S and HA- 2 AR-HEK293S cells, respectively) ( Figure 1D ).
 2 AR promotes a Gs-dependent but cAMP-independent Ca 2+ response:
To probe the mechanism underlying the  2 AR-mediated Ca 2+ response, we first examined the Gs/cAMP pathway in the HA- 2 AR-HEK293S cell line, which produces a larger Ca 2+ response following stimulation, thus facilitating its mechanistic dissection. To confirm the involvement of Gs, the primary G protein-coupling partner of the  2 AR, we tested the effect of overnight pre-treatment with cholera toxin (CTX) to down-regulate Gs signalling (Levis and Bourne, 1992), as well as the effect of acute pre-treatment with a small molecule inhibitor of Gs, NF449 (which prevents GDP/GTP exchange (Hohenegger et al., 1998) ). We found that the ISO-stimulated Ca 2+ response was significantly inhibited by both CTX and NF449 pre-treatment (Figure 2A ), suggesting the This article has not been copyedited and formatted. The final version may differ from this version. involvement of Gs in the β 2 AR-mediated Ca 2+ response. However, while chronic pre-treatment with CTX led to the expected inhibition of Gs activation measured using a bioluminescence resonance energy transfer (BRET)-based biosensor that monitors the separation between Gs and G1 as a reporter for G protein activation (Gales et al., 2005) , acute pre-treatment with NF449 had no impact on Gs activation ( Figure 2B ), indicating that its effect on the  2 ARpromoted Ca 2+ response resulted from another mechanism of action. This is consistent with the fact that, although a potent and selective inhibitor of Gs, NF449 contains multiple negative charges (El-Ajouz et al., 2012) that impede its cell permeability and likely restrict its effect to extracellular target(s) in cell-based assays. Observations that NF449 is also a potent antagonist of purinergic P2X and P2Y receptors (Braun et al., 2001; Kassack et al., 2004) provided valuable insights into additional mechanistic components underlying the  2 AR-stimulated Ca 2+ response, as discussed below. However, the inhibitory effect of sustained CTX treatment supported a role for Gs in the Ca 2+ response.
To confirm the role of Gs in the cytoplasmic Ca 2+ increase, we genetically deleted functional Gs from HEK293 cells using the CRISPR/Cas9 system (ΔGs-HEK293). The genetic characterization of three ∆Gs cell clones is presented in Supplemental Figures 1-4. Loss of both the long (GαsL) and the short (GαsS) forms of Gαs was confirmed in 3 ΔGs-HEK293 clones ( Figure 2C) . 3 ΔGs-HEK293 selected clones (Supplemental Figure 4B ). Furthermore, the ISO-promoted increase in intracellular Ca 2+ was also found to be inhibited in ΔGs-HEK293 cells ( Figure 2E , Supplemental Figure 4C ), while the response to the Ca 2+ ionophore, A23187, was similar to that observed in parental HEK293 cells ( Figure 2F Supplemental Table 3 .
We next assessed the role of the Gs-, and adenylate cyclase (AC)-dependent second messenger cAMP in the ISO-promoted Ca 2+ response. Pre-treatment with SQ22536, a pharmacological inhibitor of AC, significantly inhibited ISO-promoted cAMP production (by 43%; Figure 3A ), yet it failed to block the Ca 2+ response ( Figure 3B ), producing a response higher than in the absence of the inhibitor. To further confirm this surprising result, we directly assessed whether increases in intracellular cAMP alone were capable of generating a Ca 2+ response. Stimulation with forskolin (Fsk), which increases cAMP independently of β 2 AR activation through the direct activation of AC (Seamon et al., 1981) , increased the intracellular cAMP to a similar level as obtained for ISO ( Figures 2D and 3C ), yet elicited only a marginal Ca 2+ response ( Figure 3D ). Further supporting these results, the cell permeable cAMP analog, 8- bromo-cAMP, elicited a similarly weak Ca 2+ response ( Figure 3E ). Taken together, our data indicate the  2 AR-promoted increase in intracellular Ca 2+ occurs predominantly independently of cAMP production. response (see Figure 2A ), we assessed additional purinergic receptor antagonists to test the potential role of this receptor family. Pre-treatment with a pan-purinergic receptor antagonist, suramin, significantly inhibited the ISO-promoted increase in intracellular Ca 2+ ( Figure 4A ), while the pan-adenosine receptor antagonist CGS 15943 had no effect ( Figure 4B ). Gene expression microarray analysis of HA-β 2 AR-HEK293S cells indicated the expression of several P2X purinergic ion channels and P2Y purinergic GPCRs in this cell line (Supplemental Figure   6 ). To determine the identity of the purinergic receptor(s) involved in the Ca 2+ response, we selectively inhibited the most highly expressed subtypes. NF279 (P2X1-selective), 5-BDBD (P2X4-selective) and A804598 (P2X7-selective) were without effect, while NF157 (P2Y11/P2X1-selective) and NF340 (P2Y11-selective) significantly inhibited the ISO-promoted Ca 2+ response ( Figure 4C ), suggesting a role for the P2Y11 purinergic receptor. The effect of NF449 (Figure 2A ), NF340 and NF157 ( Figure 4C ) was specific to the  2 AR-stimulated response since these compounds did not significantly inhibit the carbamylcholine chloride (Cch)stimulated increase in Ca 2+ via endogenously expressed Gq-coupled muscarinic receptors in HAβ 2 AR-HEK293S cells ( Figures 4D) . The effect of the P2Y11-selective antagonist, NF340, was concentration-dependent and resulted in a decrease in the E max of the ISO-promoted Ca 2+ response, with no significant effect on the EC 50 ( Figure 4E ), confirming that its effect does not occur directly through a competitive blockade of the  2 AR but instead suggesting a noncompetitive antagonism of the response. Furthermore, both NF340 and NF157 were found to progressively decrease the ISO-promoted Ca 2+ response in a dose-dependent manner, with potencies compatible with their affinity for the purinergic receptors ( Figure 4F) .
Involvement of purinergic receptors in the
A previous study demonstrated that β 2 AR activation could induce the release of adenine nucleotides from HEK293 cells (Sumi et al., 2010) . To determine if the  2 AR promotes a Ca 2+ response through the release of an extracellular mediator, leading to the subsequent transactivation of a purinergic receptor, we performed co-culture experiments in which parental HEK293S cells transfected with the obelin Ca 2+ biosensor (obelin-HEK293S responder cells) were co-cultured at a 1:1 ratio with either parental HEK293S cells or with HA-β 2 AR-HEK293S cells not expressing the biosensor (releaser cells). When obelin-HEK293S responders were cocultured with releaser cells overexpressing the β 2 AR (HA-β2AR-HEK293S), a significant potentiation in the Ca 2+ response was observed following ISO treatment compared to co-culture with parental HEK293S releaser cells ( Figure 5A ), suggesting a role for the  2 AR-dependent release of an extracellular mediator acting in a paracrine manner. As a control experiment, we examined the Ca 2+ response to Cch stimulation in both co-culture conditions and found no significant difference ( Figure 5B ), further supporting the β 2 AR-specificity of this paracrine signalling response.
Since both ATP and ADP adenine nucleotides act as agonists for the P2Y11 receptor (van der Weyden et al., 2000) , we assessed the role of extracellular adenine nucleotides in the β 2 ARpromoted Ca 2+ response, by pre-treating cells with apyrase, a cell-impermeable enzyme that hydrolyses both ATP and ADP to AMP. Apyrase treatment decreased both the efficacy (34% decrease in E max ) and potency (increase in EC 50 from 9.2x10 -8 M to 1.7x10 -6 M) of the ISO-This article has not been copyedited and formatted. The final version may differ from this version. promoted response ( Figure 5C ), consistent with the depletion of an extracellular mediator released upon β 2 AR activation and acting in trans on the P2Y11 receptor. The Cch-mediated Ca 2+ response, on the other hand, was not inhibited and instead was increased following apyrase treatment ( Figure 5D ). Consistent with adenine nucleotides being the paracrine mediator responsible for the transactivation, ISO treatment promoted the release of ATP from HA-β2AR-HEK293S cells ( Figure 6A) , with kinetics similar to those of the ISO-promoted Ca 2+ response (reaching a maximum at 15 sec and returning to basal levels by 60 seconds). This ATP release was blocked by the β 2 AR-selective antagonist, ICI 118,551, supporting a role for β2AR in the response ( Figure 6B ). These results are consistent with the hypothesis that β 2 AR activation leads to the release of adenine nucleotides, which can act in trans on P2Y11 receptors to activate a Ca 2+ response.
P2Y11 transactivation elicits a Gq-dependent increase in Ca 2+ from intracellular stores:
To investigate the potential role of Gq activation following P2Y11 transactivation (Qi et al., 2001) , we tested the effects of overexpressing either WT Gq or a dominant-negative mutant form of Gq (Gq-Q209L/D277N). Overexpression of WT Gq in HA- 2 AR-HEK293S cells increased the magnitude of the ISO-promoted Ca 2+ response, whereas overexpression of Gq-Q209L/D277N or pre-treatment with the Gq-selective inhibitor FR900359 (Schrage et al., 2015) completely abolished the response (Figure 7) . These results further support the involvement of a Gq-coupled receptor downstream of the β 2 AR in the Ca 2+ response.
We next assessed whether the increase in intracellular Ca 2+ occurs via release from intracellular stores, as is typical for Gq-mediated responses. For this purpose, cells were pretreated with the IP 3 receptor antagonist, 2-APB, the cell-permeable Ca 2+ chelator, BAPTA-AM, or the sarco/endoplasmic reticulum Ca 2+ -ATPase inhibitor, thapsigargin (TG). Upon stimulation This article has not been copyedited and formatted. The final version may differ from this version. with ISO, the Ca 2+ response was completely blocked by all three inhibitors ( Figure 8A ). These inhibitors had a similar effect on the Cch-mediated Ca 2+ response, which activates a wellcharacterized IP 3 -dependent pathway via activation of Gq-coupled muscarinic receptors (Caulfield, 1993) ( Figure 8B ). Together these data are consistent with the proposed transactivation of the Gq-coupled P2Y11 receptor upon activation of the  2 AR. This article has not been copyedited and formatted. The final version may differ from this version. 
Discussion:
In this study, we describe a new node in the β 2 AR signalling network involving a Gsdependent but cAMP-independent release of ATP, which transactivates P2Y11 purinergic receptors and subsequently initiates a Gq-dependent mobilization of intracellular Ca 2+ . This discovery is consistent with the accumulating reports that receptor transactivation, via the production and/or release of an extracellular mediator acting on a distal receptor, represents a bona fide signalling event for many GPCRs (Ostrom et al., 2000; Gschwind et al., 2001; Lee et al., 2002; Sumi et al., 2010) . Given that the β 2 AR and the P2Y receptors are co-expressed in various non-excitable tissues, including the brain, gastrointestinal tract, lung, adipocytes, kidney, skeletal muscle, heart and liver (Andre et al., 1996; Nicholas et al., 1996; Moore et al., 2001) , the results obtained in the current study could provide additional insight into how β 2 AR and P2Y receptors might collaborate in normal conditions and pathophysiology.
In addition to characterizing a new signalling modality for the 2AR, the present study introduces a new genetically engineered HEK293 cell line lacking both members of Gs (Gs and G olf ), offering a powerful tool to directly assess the contribution of Gs to cellular event. Current methods to investigate the role of Gs involve either overnight treatment with CTX, which initially causes chronic activation of Gs to stimulate its downregulation, the use of the few currently available small molecule inhibitors, which provide poor target specificity, and/or inhibition of the downstream effectors AC or protein kinase A. Genetic knockout of Gs provides a useful tool to specifically investigate the role of Gs and, as was the case in the present study, allow the discovery of Gs-dependent responses that do not require cAMP production. These cells should prove useful in future studies to explore additional non-canonical Gs signalling pathways. This article has not been copyedited and formatted. The final version may differ from this version. Although the β 2 AR-mediated release of adenine nucleotides has been described previously (Baker et al., 2004; Sumi et al., 2010) , the functional consequences of this signalling event are just beginning to be explored. P2Y11 mRNA was the most abundant in HEK293S cells and it has the highest affinity for ATP compare to other purinergic receptors expressed in these cells (von Kügelgen et al., 2006 ). Yet, the capacity of the  2 AR to stimulate the release of ATP may in fact lead to the activation of other purinergic receptor subtypes in cells expressing a different repertoire or spatial organization of receptors.
The mechanism described in this study differs from previous reports of β 2 AR-mediated Ca 2+ responses in non-excitable HEK293 cells, which suggested a cAMP-dependent increase in intracellular Ca 2+ , through a mechanism involving exchange protein directly activated by cAMP (EPAC) and phospholipase Cε or calcium release activated calcium (CRAC) channels (Schmidt et al., 2001; Keller et al., 2014) . Although we cannot exclude a contribution of these mechanisms to the Ca 2+ response studied here, our data clearly indicate that β 2 AR activation in HEK293 cells can elicit a Ca 2+ response independently of cAMP since blocking approximately 50% of the cAMP production did not affect the Ca 2+ response (Figure 3A,B) . Moreover, direct elevation of cAMP following treatment with forskolin or the cAMP analogue 8-Br-cAMP elicited only marginal Ca 2+ responses compared to  2 AR stimulation ( Figure 3D ,E). Whether CRAC could subsequently contribute to the response following the initial Ca 2+ mobilisation from the ER pool described in the current study has not been investigated. Interestingly, these previous studies used the Fura-2 indicator dye to measure intracellular Ca 2+ , which is dissolved in the non-ionic not interfere with this ATP release mechanism and may have aided in the elucidation of the mechanism described in the current work.
This collaboration between the β 2 AR and purinergic receptors may be of particular relevance in the context of the airway epithelium. Indeed, the β 2 AR plays an important role in the cAMPdependent secretion of airway surfactants, ciliary beating and regulation of mucosal clearance (Wright and Dobbs, 1991; Salathe, 2002) , properties that contribute to the therapeutic success of β 2 AR agonists for the treatment of asthma (Giembycz and Newton, 2006) . Interestingly, activation of Gq-coupled receptors and increases in intracellular Ca 2+ promote undesirable inflammatory responses in pulmonary tissues (Barnes, 1998; Rider et al., 2011) . Furthermore, an increase in purine nucleotide release from the airway epithelium is a hallmark of inflammatory , 2010) . Given the beneficial effects of cAMP production and deleterious consequences of increases in intracellular Ca 2+ in airway epithelia, the identification of functionally selective  2 AR ligands that stimulate cAMP production without promoting Ca 2+ mobilization could represent a desirable class of  2 AR agonists for the treatment of pulmonary disorders. Salmeterol, a clinically effective  2 AR agonist used in the treatment of asthma, exhibits less side effects than what is typically associated with chronic use of other  2 AR agonists (Cazzola et al., 2013) . Biased signalling studies have also shown that salmeterol is highly efficacious towards cAMP production but does not increase intracellular Ca 2+ (van der Westhuizen et al., 2014) . Given the results obtained in the current work, future studies examining the influence of purinergic receptor transactivation in the context of β 2 AR-targeted treatment of This article has not been copyedited and formatted. The final version may differ from this version. pulmonary disorders could be of great interest. Indeed, it is tempting to speculate that optimal therapy for such pulmonary disorders might involve harnessing the therapeutic benefit of adrenergic-mediated cAMP/PKA activity while avoiding the pro-inflammatory effect of purinergic transactivation and subsequent Ca 2+ -dependent signalling.
Our study demonstrates a novel "inside-out" pathway for the β 2 AR, adding to its signalling repertoire the transactivation of purinergic receptors and stimulation of Ca 2+ mobilization. Given the preponderance of data supporting such transactivation mechanisms for both the β 2 AR and other GPCR family members, we propose that such "inside-out" signalling events are not rare occurrences and instead represent a common signalling motif for GPCRs that may provide tissue-specific signalling in cells expressing a given repertoire of receptors.
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